Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.

Published

Journal Article

Antimicrobial susceptibility testing of 192 group B streptococcal isolates from patients with invasive disease demonstrated that 31 (16%) were resistant to erythromycin and 17 (9%) were resistant to clindamycin. One isolate demonstrated high-level resistance to streptomycin, but none was highly resistant to gentamicin. Erythromycin and clindamycin are no longer reliable empirical alternatives to penicillin for the treatment and prevention of group B streptococcal infections.

Full Text

Duke Authors

Cited Authors

  • Murdoch, DR; Reller, LB

Published Date

  • December 2001

Published In

Volume / Issue

  • 45 / 12

Start / End Page

  • 3623 - 3624

PubMed ID

  • 11709354

Pubmed Central ID

  • 11709354

Electronic International Standard Serial Number (EISSN)

  • 1098-6596

International Standard Serial Number (ISSN)

  • 0066-4804

Digital Object Identifier (DOI)

  • 10.1128/AAC.45.12.3623-3624.2001

Language

  • eng